Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.crmeth.2022.100279
PubMed Identifier: 35975199
Publication URI: http://europepmc.org/abstract/MED/35975199
Type: Journal Article/Review
Volume: 2
Parent Publication: Cell reports methods
Issue: 9
ISSN: 2667-2375